All Articles

With six straight J.D. Power wins and stellar local reviews, Renewal by Andersen isn't just selling windows. It's selling a business model.

LSBF and SAFRA's new bond-free sponsorships are more than a gift; they are a strategic investment in national talent and a new model for corporate-community partnership.

Security National Financial boosts profits despite falling revenue, revealing a masterclass in operational efficiency and a long-term strategy that defies convention.

A new integration embeds anti-money laundering checks into law firm workflows, answering intense regulatory pressure with a new model for efficiency.

Draganfly posts 26% revenue growth and secures major defense contracts, but a widening comprehensive loss reveals the high cost of its aggressive expansion strategy.

Ealixir's Q2 results reveal a narrowing loss and revenue jump, driven by its new AI engine EALUMINATE and a strategic, scalable move into Italian media.

As Enterprise Products meets investors, it's not just about record profits. It's a dialogue on trust, transition, and the future of America's energy backbone.

As Johnson & Johnson prepares for a key investor conference, its strategy hinges on a potent mix of new drugs, robotic surgery, and a leaner focus.

With a strong cash runway, Nkarta pushes its off-the-shelf NK cell therapy into community clinics, setting the stage for a pivotal data reveal in 2026.

With promising early data and a robust balance sheet, Palisade Bio is advancing its targeted IBD therapy, PALI-2108, into crucial Phase 2 trials.

Amid Q2 losses, Proficient Auto Logistics acquires Hansen & Adkins, betting big on consolidation to navigate an auto haul industry facing an 'inflection point'.

As KNOT Offshore Partners prepares its Q2 earnings report, the market watches closely. Brazil's oil surge provides a powerful tailwind amid a buyout offer.

Amplify Energy touts a major profit swing and a new stock buyback, but a look under the hood reveals a complex picture of derivative gains and real-world challenges.

FutureFuel's stunning $25.6M profit swing reveals a blueprint for resilience, powered by regulatory tailwinds in biofuels and reshoring in chemicals.

With major clinical trials progressing and a $110M war chest, Orchestra BioMed is orchestrating a potential shift in cardiovascular treatment.

Toronto's Kepler Communications is betting big on optical links and on-orbit computing. A new deal with Rocket Lab signals a major escalation in the race to control space data.

Getty Images faces a liquidity crisis with soaring debt and a failed merger, raising doubts about its future despite some growth in its core business.

P3 Health Partners stuns Wall Street with a swing to profitability, but a deeper dive reveals one-time gains and a strategic pivot. Is this the new playbook?

Amidst declining revenue and layoffs, Rapid7's new CEO is making a bold bet on a focused, AI-driven strategy. Is this the path to renewed strength?

Angie O'Leary's promotion at Commercial Vehicle Group is more than a new title. It's a strategic bet on continuity to navigate a turbulent EV transition.